Steven O’Day: I am thrilled to be joining Dr. Benjamin Schlechter, Dr. Pashtoon Kasi, and Phuong Ly-Gallagher for an engaging discussion on “The Next I-O Revolution”.

Steven O’Day, Chief Medical Officer at Agenus, recently shared on LinkedIn:

“I am thrilled to be joining Dr. Benjamin Schlechter, Dr. Pashtoon Kasi, and Phuong Ly-Gallagher for an engaging discussion on ‘The Next I-O Revolution’. On October 18th, Endpoints News will host a webinar where we will delve into the latest breakthroughs in the next-generation investigational immunotherapy treatments, including Agenus’ botensilimab and balstilimab, shedding light on their potential impact against traditionally ‘cold’ tumors, like colorectal cancer. Join us!

Registration is available here.”

Source: Steven O’Day/LinkedIn